D. E. Shaw & Co., Inc. Trinity Biotech PLC Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$3.76 - $5.08 $261,733 - $353,618	-69,610 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.5 - $5.77 $535,527 - $686,664	-119,006 Reduced 63.09%	69,610 $356,000
Q3 2017 Nov 14, 2017	BUY	$5.16 - $5.67 $973,258 - $1.07 Million	188,616	188,616 $1.06 Million

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $24.4M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.